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Objective: Constrictive external Nitinol meshes have been shown to suppress neointimal tissue formation and preserve
endothelial integrity in vein grafts. As this mitigating effect increased with the degree of constriction, we investigated
whether extreme constriction was possible without leading to detrimental luminal encroachment.
Methods: A senescent non-human primate model (Chacma baboons/bilateral femoral interposition grafts) mimicking the
clinical size-mismatch between vein grafts and run-off arteries was used. Control grafts were either untreated (group 1)
or spray-coated with fibrin glue (group 2). Nitinol meshes constricting the lumen by<80% (group 3) were compared with
longitudinally pleated meshes of identical circumference that constricted the lumen by>90% (group 4). Anastomotic size
mismatch at implantation was expressed as quotient of cross-sectional area of run-off artery to vein graft (QC).
Results: At 6 months, all vein grafts without mesh support showed thick eccentric layers of neointimal tissue (group 1:
348  130 m [QC median at implant 0.19]; group 2: 318  142 m [QC median at implant 0.17]). Fibrin
glue-spraying had no effect. In contrast, neointimal tissue was absent in all mesh-supported grafts (P < .007 in all cases)
both at 6 weeks/6 months (group 3: 7.5  8.8 m and 2.5  4.4 m [QC median at implant 1.47]; group 4: 1.3  0.6
mand 3.8 5.6m [QCmedian at implant 3.09]). Except formild tissue buckling (fold height<356m) in one group
3 graft, none of the mesh-constricted grafts showed wall folds. Endothelial coverage was only complete in the
mesh-supported groups (100% in group 3 and 4 vs 85  14%; P < .023 in group 1). Fibrin glue alone (52  48%) did
not preserve endothelialization of control grafts (P < .38).
Conclusion: Extreme vein graft constriction using external Nitinol meshes is possible without detrimental tissue buckling.
Although moderate constriction was found to be sufficient for mitigating diffuse intimal hyperplasia and endothelial
detachment, extremer constriction may occasionally be required to eliminate luminal irregularities. ( J Vasc Surg 2009;
49:1532-42.)
Clinical Relevance:Neointimal proliferation holds a key to vein graft failure. Among the many factors contributing to the
development of flow-limiting intimal hyperplasia, low shear stress and high circumferential wall stress play a key role.
Constricting vein grafts with external meshes counters these forces through higher flow velocity and smaller diameters.
Eliminating luminal irregularities additionally alleviates turbulences, a main trigger of focal stenoses. Being able to
distinctly constrict vein grafts without creating folds protruding into the lumen will offer a clinical tool expected to
distinctly improve the performance of vein grafts.Both in peripheral and coronary artery bypass surgery the
predominant failure mode of vein grafts is mid-graft intimal
hyperplasia.1-4 The sequence of events often begins with
diffuse neointimal tissue proliferation which develops in 75%
of grafts within 1 year of implantation.2 It is mainly triggered
From the Christiaan Barnard Division of Cardiothoracic Surgery, University
of Cape Town;a Medtronic Science and Technology, Medtronic Inc;b and
Medtronic Cardiovascular.c
Competition of interest: This study was mainly funded through a research
collaboration grant by Medtronic Inc (Minneapolis, Minn) to the Uni-
versity of Cape Twon. The salaries of DB, MB, and TF are fully funded by
Medtronic and that of PH is partly funded.
Reprint requests: Peter Zilla, MD, PhD, Christiaan Barnard Division of
Cardiothoracic Surgery, University of Cape Town, Faculty of Health
Sciences, Cape Heart Centre, Anzio Road, 7925 Observatory, Cape
Town, South Africa (e-mail: peter.zilla@uct.ac.za).
0741-5214/$36.00
Copyright © 2009 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2009.01.068
1532by low shear stress5-8 and high wall tension9-11 – both a conse-
quence of vein dilatation12 and diameter mismatch with the
host artery. Reduced to a single phenomenon, the vein graft
diameter is simply too large for its run-off vessel. However,
while an overall diameter mismatch explains most of the
pathophysiology behind diffuse intimal hyperplasia, the dom-
inant triggers behind focal intimal hyperplasia are localized
flow discrepancies13 resulting from luminal irregularities.2,8
Given the fact that focal intimal hyperplasia carries a more than
10-times higher risk of graft occlusion than a diffuse one,2 the
clinical importance of eliminating luminal irregularities is ob-
vious.
Therefore, when Parsonnet et al14 suggested an expansion-
limiting external polypropylene mesh for vein grafts as early
as in 1963, the goal was not only to increase the flow
velocity through diameter reduction but also to eliminate
luminal irregularities.
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the mitigating effect of external vein support on intimal
hyperplasia,15-19 the optimal size and material of the
meshes remained a contentious issue. However, the 100%
occlusion rate in a most recent clinical trial18 using over-
sized meshes has tilted the debate towards constrictive
meshes. By choosing a non-human primate model that
emulated the dimensional ratios between vein grafts and
coronary arteries, we could show that external meshes
could constrict the diameter of vein grafts by as much as
50% in order to create a lumenal size match with the run-off
artery and thus optimally preserve the endothelium and
mitigate intimal hyperplasia.19 At the same time, the anal-
ysis of a large cohort of saphenous veins of patients under-
going coronary artery bypass grafting showed that an aver-
age diameter-constriction of 26% would suffice to eliminate
luminal irregularities in a majority of cases.20 In order to
achieve this in all patients, some vein grafts would need to
be constricted by up to 60%.20 Furthermore, distinct con-
striction may not only be needed for the elimination of
lumenal irregularities but also for size-matching a large vein
diameter to a small run-off vessel in order to reach intimal-
suppressive shear forces. However, as much as such a dis-
tinct vein graft constriction was experimentally tolerated in
veins of comparable wall thickness to that of human saphe-
nous veins,19 the surgical concern regarding buckling due
to tissue redundancy needs to be addressed. Therefore, the
present study looked into ways of distinct diameter reduc-
tion of vein grafts while preventing unwanted tissue folds in
the lumen. By using the same constrictive Nitinol meshes
that were previously shown to suppress intimal hyperplasia,
a baseline could be established. By longitudinally pleating
these meshes, the outside circumference was maintained
while distinctly reducing the cross-sectional area. The ex-
tension of the implantation period from 12 weeks to 180
days excluded the possibility of observing a short-term
benefit.
MATERIALS AND METHODS
Study purpose and design. Senescent Chacma ba-
boons were chosen as their vascular injury response differs
least from humans.21 Superficial femoral veins were used as
femoral artery interposition grafts (n  24/n  4/length
53  4.4 mm per group) since this combination was
previously shown to most closely emulate the dimensional
mismatch between vein grafts and host arteries in hu-
mans.19,20 As control veins and 50% constricted vein grafts
had previously been directly compared in bilateral implants,
groupings were chosen that separately addressed the two
present questions namely the effect of fibrin glue on its own
and the ability to constrict beyond previously tested limits.
Therefore, control groups were contralaterally compared to
determine the effect of sprayed fibrin glue. The rationale
behind including the spray-coating of one control group
were previous reports of fibrin glue having an effect on its
own.22 Similarly, braided 3.3 mm Nitinol meshes were
contralaterally compared with identical but longitudinally
pleated meshes to determine the effect of 90% constric-tion. The purpose of pleating was to investigate whether a
changed ratio of perimeter to cross-sectional area allows to
further constrict the diameter of vein grafts without causing
tissue buckles and folds. To assess early signs of vein graft
buckling within the constrictive Nitinol meshes, a 6-week
observation period was added for mesh-supported groups.
To assess the biological effect of external vein graft support,
implantation periods of 6 months were chosen for all
groups.
Nitinolmeshes. Based on the previous demonstration
in the baboon model that a reduction of anastomotic size
mismatch through a 50% diameter constriction was optimal
for endothelial preservation and suppression of intimal
hyperplasia, an inner diameter (ID) of 3.39/3.37 mm (at
120/80 mm Hg) was chosen for the Nitinol meshes.
Nitinol (BB Ni-Ti alloy: nickel 56.0 wt%, titanium 43.9365
wt%, carbon 0.033 wt%, oxygen 0.028 wt%, hydrogen
0.0025 wt%) wires (thickness: 50 m; Fort Wayne Metals,
Fort Wayne, Ind) were braided using 24 wires on a 48-
carrier braiding machine (Medtronic Cardiovascular, Dan-
vers, Mass). Longitudinal pleating of the meshes to crown-
heights of ca 500 m during heat-setting (Medtronic
Cardiovascular) achieved a further 40% reduction in cross-
sectional area without diminishing the circumference.
Compliance (measured by volumetric displacement testing;
DCT3 compliance tester, Dynatek Dalta, Galena, Miss,
distilled water, 37°C) was found to be negligible (0.9 
0.1%/100 mm Hg at 120/80 mm Hg) in the non-pleated
controls and 5.6 0.4%/100 mm Hg in the longitudinally
pleated meshes.
Mesh dilatation at explantation was determined on the
basis of cross-sectional image-analysis of resin-embedded
mid-graft ring sections (Nikon, Tokyo, Japan, E 1000
0.5macro-lens/Leica QWin Pro V2.5), pressure-fixed at
120 mm assuming hypothetically circular-shaped meshes of
equivalent cross-sectional area for the pleated group.
Experimental surgery. All experiments were ap-
proved by the Animal Ethics Committee of the University
of Cape Town. Surgery and pre- and postoperative care
complied with the “Principles of Laboratory Care”. Adult
Chacma baboons (n 12; 22.8 6.0 kg) were provided by
the breeding and quarantine facilities of the South African
Medical Research Council (MRC) at Delft/Cape Town,
South Africa. Bilaterally harvested reversed superficial fem-
oral veins were used as grafts. In the mesh supported groups
(2 groups; 2 time points each; n  4 per group and time
point) veins were gently pulled through an introduction
straw on which the Nitinol mesh was mounted. By gently
pulling back the straw, the mesh ‘snuggled’ against the
outer vein wall with minimum distension force and without
affecting the diameter. Non mesh-supported control grafts
were either implanted without any external support (n 4)
or after applying a thin layer of sprayed fibrin glue (n  4)
(Tisseel, Baxter International Inc, Deerfield, Ill). Veins
were then implanted as interposition grafts into the super-
ficial femoral artery using running 7/0 Prolene (Ethicon
Inc, Somerville, NJ). At completion of the anastomoses,
the cross-clamp was intermittently opened to allow the
to the artery with suspension stitches.
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vein graft before the Nitinol mesh was pulled 5-7 mm
across the anastomosis (Fig 1).
At explantation, grafts were perfusion-rinsed with hep-
arinized Ringer’s solution before perfusion fixation with 1L
of 10% formalin in PBS (iliac cannulation; perfusion pres-
sure of 120 mm Hg). Given the natural recoil tendency of
a non-pressurized artery, vessels were fixed at systolic pres-
sures to preserve those lumenal dimensions for analysis
which exist during the forward flow phase and whose shear
forces largely determine intimal hyperplasia. After main-
taining this pressure for 30 minutes, grafts were resected en
block and post-fixed for 24 hours. Following en bloc
resection, a 15-mm long cross-section specimen was cen-
trally excised. Following macroscopic image analysis, spec-
imens were further sub-divided for resin embedding, par-
affin embedding (following gentle ‘de-wiring’), and
electron microscopy.
Macroscopic graft dimensions. Vein harvest meth-
ods strictly followed no-touch principles to prevent spasm
and thus allow for the assessment of in situ dimensions.
Using a caliper, ODs were carefully measured in the middle
of the segment assigned for excision and after interposition
grafting during systolic vessel expansion. Macroscopic im-
age analysis of mid-graft sections used QWinPro (V 2.5;
Leica Microsystems Imaging Solutions, Wetzlar, Ger-
many). Luminal dimensions were calculated on the basis of
ODs and wall thicknesses of control samples. A compres-
sion factor of32% was factored in for the wall thickness of
mesh-supported grafts.19 The degree of dimensional mis-
match between vein grafts and host arteries was ex-
pressed as the quotient of cross-sectional areas (Qc 
ah/ag whereby ah represented the cross-sectional area of
the host artery and ag that of the interposition graft).
Light microscopy
Paraffin histology. For routine light microscopy he-
matoxylin and eosin (H&E), modified Elastic Masson
trichrome and modified Movat stains were viewed under a
Nikon E 1000M and a Nikon Coolscope (Nikon). A series
of 25 consecutive sections cut at 3 m were used for
paraffin histology. Two series approximately 300 m apart
were analyzed. Immunofluorescence techniques were used
for von Willebrand factor (VWF) labeling (blood surface
endothelialization/Dako, Glostrup, Denmark) and -actin
(Abcam, Cambridge, UK). Nuclear counterstains used
Dapi (Invitrogen/Molecular Probes, Carlsbad, Calif).
Immunofluorescence-microscopy was performed on a Ni-
kon 90i microscope (Nikon).
Resin histology. Non-dewired mid-graft sections
were infiltrated with methyl methacrylate resin (MMA)
(Sigma-Aldrich, Steinheim, Germany). Dynamic sample-
infiltration was done over 3 days through increasing con-
centrations of benzoyl peroxide followed by cold curing
polymerization for 72 hrs at20°C under exclusion of air.
Initially, 100-m sections were cut with an Isomet Preci-
sion Saw (Buehler, Dusseldorf, Germany) and then groundFig 1. Mesh-constricted grafts at implantation: macroscopic
appearance of the anastomotic region of reversed interposition
vein grafts in the superficial femoral artery of senescent Chacma
baboons. Braided Nitinol meshes were used to constrict the
diameter of the vein grafts by 50% to match the size of the artery
(a). By longitudinally pleating the Nitinol meshes (b) a distinct
further constriction could be achieved without affecting the
circumference of the vein graft. In order to prevent diameter
changes of the meshes through longitudinal constriction,
meshes extended across the anastomoses ( ) and were fixeddown to between 4-8 m with a Metaserve 2000
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of paper to polish. The resin was not removed and the
slides were stained with H&E before being mounted
with Glycergel (Dako Cytomation), an aqueous mount-
ing medium. Thin sections were cut on a Leica Polycut
using a tungsten carbide blade and the resin removed
with 2-methoxyethylacetate to enable staining with elas-
tic masons and movat.23
Image analysis. For image analyses, composite images
were assembled from digital single-frames captured at 4
or 10magnification (Nikon Eclipse 90i and Nikon Cool-
scope) using Eclipse Net (Laboratory Imaging, Prague,
Czech Republic) software. Lumen- and mesh-dimensions
were obtained from resin sections. To assess graft shrinkage
or dilatation, the cross-sectional areas demarcated by the
internal elastic membranes (IEM) were used to approxi-
mate the IEM to perfect circles from which the ‘sub-intimal
diameters’ could be calculated.
Intimal hyperplasia tissue (IH) was clearly discernable
both by its demarcation through a largely present though
sometimes fragmented internal elastic lamella (IEL) and its
lack of elastic fibers within. Muscularity was defined as the
partial cross-sectional area of media smooth muscle cells
within the boundaries of the media.
Scanning electron microscopy. Specimens were
post-fixed in 2% glutaraldehyde (GA) in Cacodylate buffer
at 4°C and iso-osmolarity. After critical point drying (CPD
7501, Polaron, Watford, UK) and sputter coating (Sputter
Coater Polaron) specimens were viewed in a JEOL JSM
5200 (Jeol, Tokyo, Japan) scanning electron microscope.
Standard error of the mean (SEM) images were digitally
captured by Orion V5.20 software (Orion, Brussels, Bel-
gium) at 15 magnifications. Zooming in on parallel live-
images allowed verification in situations where the low-
magnification pictures were inconclusively interpreted. For
the quantification of surface endothelialization, Scion Im-
age Software (NIH, Bethesda, Md) was used.
Statistical analysis. Continuous numerical data are
expressed as means sample standard deviations. Post-hoc
comparisons between continuous datasets were performed
using the unpaired t test. Endothelial confluency data,
which were seen to have unequal variances, were compared
using non-parametric Kruskal Wallis/Wilcoxon testing. Pa-
tency data were compared using Fisher’s exact test. Two-
tailed P values  .05 were regarded as demonstrating
statistical significance.
RESULTS
The 180-day graft patency was 75% in both control
groups and 100% in both mesh-supported groups. There
was no statistically significant difference between the
groups.
Graft pathology
Gross morphology. After half a year of implantation,
control grafts showed a thick whitish vessel wall both in the
untreated and the fibrin glue-sprayed group. Their blood
surface was glistening and thrombus-free. In the non-treated control grafts, smooth areas sometimes alternated
with ‘wavy’ stretches almost appearing as if small zones had
bulged out while others remained unaffected. Compared
with the time of implantation, histo-morphometric mea-
surements showed a 158.5  220.2% increase in wall
thickness in the untreated controls (NS) and a 264 67.5%
increase in the fibrin glue-sprayed control group (P 
.013).
Mesh-supported groups showed a thin and delicate vessel
wall regardless of the mesh type (Fig 2). Although delicate
without exception, the overall wall thickness further dimin-
ished between 6 weeks and 6 months. Generally, the tissue
between the blood surface and the mesh was so thin that
the mesh almost appeared to lie underneath a transparent
film (Fig 2).
Endothelium. At 6 months, both control groups
showed a patchy but largely surface-covering endothelium
with no significant difference between untreated vein grafts
and fibrin glue-sprayed ones (84.7 13.6% vs 51.9 48.3;
P  .38). At that point in time, all mesh-supported grafts
showed a 100% confluent endothelium (P  .023 vs con-
trols). This confluence was already present at 6 weeks
except for one graft in each group (graft 3 in the non-
pleated group [82.3% EC coverage] and graft 4 in the
pleated group [65.4% EC coverage]).
Intimal hyperplasia. Both control groups showed a
distinct, mildly eccentric layer of typical intimal hyperplasia
tissue (Fig 3) with its abundant GAG-rich extracellular
matrix and irregularly orientated -actin-positive smooth
muscle cells on top of an often discernable internal elastic
membrane. There was no difference in intimal thickness
between the untreated control group (348 130 m) and
the fibrin glue-sprayed control group (318  142 m)
(NS) (Fig 4). The contribution of intimal hyperplasia to the
overall wall thickness in the non fibrin-treated and fibrin-
treated groups was 41.6  17.0% and 26.2  15.8%,
respectively.
In contrast, all mesh-supported vein grafts showed a
near complete absence of any intimal hyperplasia tissue (Fig
3) both at 6 weeks (7.5  8.8 m [non-pleated] vs 1.3 
0.6 m [pleated]) and 6 months (2.5  4.4 m (non
pleated) vs 3.8  5.6 m [pleated]) (Fig 4). Individually,
all mesh-supported groups had significantly less intimal
hyperplasia than either of the control groups (P  .007 in
all cases).
Media. In both non mesh-supported control groups,
the so-called ‘arterialization’ of vein grafts over time was
not reflected in an increase in smooth muscle volume.
While the thickness of the media remained largely un-
changed between the time of implantation and 6 months
(261 60 m vs 262 84 m; NS in controls and 233
44 m vs 346  134 m; NS in fibrin glue-sprayed
controls), the muscularity decreased (from 64.1 14.8% to
35.8 10.2%; P .037 in controls and from 51.5 7.2%
to 33.7  5.1%; P  .015 in fibrin glue-sprayed controls).
In mesh-supported grafts, the media dramatically decreased
in thickness within the initial 6 weeks (from 173  22 m
to 77 11 m; P  .00024 in the non-pleated group and
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group). This was followed by a mild further reduction in
thickness between 6 weeks and 6 months to 48 17 m in
the non-pleated group (P  .027) and 44  9 m in the
pleated group (P  .00030). Given the fact that the mus-
cularity remained relatively constant (44.7  4.3% [im-
plant] vs 38.3  10.7% [NS] [6 weeks] vs 56.5  20.2%
[NS] [6 months] in the non-pleated group and 53.8 
3.7% vs 52.2 3.5% [NS] vs 65.0 9.9% [P .022] in the
pleated group) a balanced atrophy of all media components
seemed to occur. In the pleated group, the media was
regularly thicker at the crowns than in between.
Adventitia and peri-adventitia. While the relatively
loose and Elastin-rich adventitia was not always clearly
discernible from the outer fibrous capsule, the latter was
clearly thicker and richer in blood vessels in the fibrin
glue-sprayed controls than the untreated controls (Fig 5).
In mesh-supported grafts, the distinct diminishing of the
adventitial and peri-adventitial tissue between 6 weeks and
6 months was primarily responsible for an overall reduction
in wall thickness during this period by 35.5  11.9 (P 
.0011) in the non-pleated group and 22.8  30.2% (P 
.067) in the pleated group.
Flow profiles
Mesh dilatation. During the initial 6 weeks of implan-
tation, a mesh dilatation of 8.1 4.0% was observed in the
non-pleated group, corresponding with an increase in lu-
minal cross-sectional area (as) of 17.0  8.5% (P  .026).
The subsequent dilatation between 6 weeks and 6 months
was negligible (1.0% ID/2.2% as; NS) (Fig 6). Longitudi-
nal pleating of the Nitinol meshes did not affect the circum-
ference (10.62 vs 10.67 mm) but led to a further reduction
of 22% in calculated mean ID and 39% in cross-sectional
area. In the pleated group, the dilatation was also most
pronounced during the first 6 weeks (21.9  5.9% ID/
48.7 14.6% as; P .0045) with no significant expansion
occurring thereafter (3.5% ID/8.9% as; P  .5). Although
‘crowns’, ie, crest regions of pleat protruding into the
lumen or adventitia, flattened over time (22.7  1.9%
during the initial 6 weeks [P  .001] and another 12.9%
until the end of 6 months [P  .024]) they maintained
272  28 m of the initial height of 422 m. While the
star-shaped cross-sectional profile was well preserved at 6
weeks, it had become less pronounced but still clearly
discernible at 6 months (Fig 6). In spite of the more
pronounced overall dilatation of the pleated meshes, its
4™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™
Fig 2. Mesh-constricted grafts at explantation: mid sections of
vein grafts externally supported by non-pleated (a and b) and
pleated (c and d) Nitinol meshes. Samples represent 6 weeks (a
and c) and 6 months (b and d) explants. Although all mesh-
supported grafts showed thin and delicate walls, it is obvious that
the wall thickness further diminished between 6 weeks and 6
months. In longitudinally opened grafts, the Nitinol mesh appears
to lie directly underneath the blood surface in the 6-month ex-
plants.
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than that of its non-pleated counterparts after 6 months of
implantation (P  .031). Overall, pleated meshes con-
stricted the luminal area of vein grafts by 90.9% (P .001).
Lumenal dimensions. The mean in situ OD/ID of
Fig 3. Histology of mid sections of vein grafts after 6 months of
implantation: The size comparison between control grafts (a and
b) and mesh supported grafts (c and d) illustrates the degree of
constriction achieved by the placement of the external Nitinol
meshes (Elastin Masson’s Trichrome stain; original magnification
40). Compared with un-treated controls (a) fibrin glue-sprayed
control grafts (b) had a slightly smaller diameter and a thicker
fibrotic adventitia. In spite of the dramatic constriction, hardly any
of the mesh supported grafts showed folds protruding into the
lumen (c and d). Although the crowns of the pleated meshes had
flattened out at 6 months, the overall star-shape of the grafts was
well preserved (d). At higher enlargement, (original magnification
200; Masson’s Elastin-Trichrome stain [a1 to d1] and Movat
[a2 to d2]) both control groups showed similar degrees of intimal
hyperplasia (a1 and a2/b1 and b2), clearly discernable from the
media by an internal elastic lamella (IEL(). The blue areas in the
neointima on Movat stains (a2 and b2) represent extracellular
matrix areas rich in glycosaminoglykanes. In both mesh-supported
groups, the compacted atrophic media borders directly on the
endothelium without a neointima (c1; d1). The accumulation of
densely packed elastic fibers in the adventitia of mesh-supported
grafts (black) is well recognizable on Movat stains (c2 and d2).superficial femoral arteries prior to graft interposition was3.84  0.39/3.05  0.04 mm and that of superficial
femoral veins was 6.30  0.99/5.21  1.12 mm. Upon
exposure to arterial pressures, the OD/ID of vein grafts of
the non mesh-supported untreated control group immedi-
ately expanded by 17.1/19.3% (NS/NS) and that of the
fibrin glue-sprayed control group by 23.6/26.7% (P 
.05/.04), respectively. After 6 months of implantation,
untreated control grafts had further mildly dilated but this
increase in sub-intimal diameter by 5.3% (NS) was coun-
teracted by intimal hyperplasia. Fibrin glue-sprayed control
grafts had become moderately constricted with a sub-
intimal diameter 19.3% smaller than at implantation (P 
.043).
At the time of implantation, the placement of external
Nitinol meshes led to a constriction of ODs/IDs of vein
grafts by 49.3  5.8/56.4  5.9% P  108/P  106)
(non-pleated group) and 61.0  4.4%/69.6  4.7% (P 
106/P  106) (pleated group).
When related to the OD of pressure-distended vein
grafts in situ, this constriction led to an excess of outer vein
wall circumference of 51.9  5.4% (non-pleated) and
52.4  4.8% (pleated), respectively. Only one 6-week
sample in the non-pleated group showed a low-profile (356
m) longitudinal fold (Fig 7) in one area and two in
another (309 m and 186 m). None of the other explants
showed any tissue folds on the luminal side.
Cross-sectional ratio. The femoral interposition
model was characterized by a luminal cross-sectional ratio
Fig 4. Image-analytical measurement of neointimal thickness:
while intimal hyperplasia was largely immeasurable in both mesh-
supported groups (- - - non-pleated; — pleated) it was distinctly
pronounced in the two control groups (– – non-treated; – – – fibrin
glue-sprayed). (Means  standard error of the mean [SEM]).of less than 1:5 between run-off artery and control grafts
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the graft lumena moderately beyond a size match with the
artery (1.5:1) while pleated meshes even reversed the cross-
sectional ratio to 3:1 (Table). Within the initial 6 weeks of
implantation, both mesh-supported groups reached di-
mensions that were roughly size-matched with their run-off
arteries (Table).
DISCUSSION
We could confirm in a senescent non-human primate
model that constrictive external Nitinol meshes are capable
of completely suppressing intimal hyperplasia in vein grafts.
By leading to a complete absence of neointimal tissue both
at 6 weeks and 6 months, constrictive mesh support con-
firmed its extraordinary efficacy10,19,24 as more than a
short-term phenomenon.
By choosing a model that mimicked the size-mismatch
between vein grafts and coronary arteries, hemodynamics
Fig 5. Control graft fibrosis: Picro-Sirius stains of collagen fibers
in control (a) and fibrin glue-sprayed (b) vein grafts. Collagen
formation was distinctly more pronounced in the fibrin glue-
sprayed group (original magnification 40).and flow-mechanics of clinical circumstances were consid-ered. By selecting a vein-source that was shown to emulate
the micro-anatomy of human saphenous veins with regards
to wall and media thickness,19 clinical conclusions could be
drawn with regard to buckling and folding under constric-
tive conditions.
When saphenous vein grafts are clinically used for cor-
onary artery bypass grafting (CABG), the dimensional mis-
match between the vein and the coronary artery corre-
sponds with a cross-sectional ratio of Qc 0.3 as opposed
to the almost size-matched internal thoracic artery (ITA)
grafts (Qc ca 0.9).
19 In contrast, under experimental con-
ditions vein grafts were often used as peripheral interposi-
tion grafts which were almost size-matched with the host
artery.12,16 Thus, their cross-sectional graft-to-artery ratio
at implantation rather resembled that of ITA grafts than
clinically implanted coronary vein grafts. Given the fact that
diffuse intimal hyperplasia is mainly triggered by wall ten-
sion and low shear stress,6-9 both a function of the graft
radius and the cross-sectional ratio, experimental large-
diameter vein grafts better reflect the clinical situation than
the often used small-calibre veins. A prerequisite is a micro-
anatomy of the vein wall that is comparable with that of the
saphenous vein. We have previously compared various vein
sources of senescent Chacma baboons with human saphe-
Fig 6. Resin-embedded mid-graft sections: at implantation non-
pleated (a and b) and pleated (c and d) Nitinol meshes measured
the same inner circumference but pleated meshes had a 39% smaller
cross-sectional area. Between 6 weeks (a and c) and 6 months (b
and d) the walls of the vein grafts became significantly thinner due
to the almost complete disappearance of the loose elastin-rich
adventitial layer between media and mesh ((). None of the
6-months implants (b and d) and none of the pleated 6-week
implants (c) showed any signs of folding in spite of the constriction
leading to a more than 50% redundancy in vein wall circumference
(original magnification 40).nous veins and found the superficial femoral vein to be
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regards to caliber mismatch and wall histology.19
Using this established animal model in our present
study, we found the cross-sectional ratio of control grafts to
their run-off vessel to be less than 0.2. Confirming previous
results,19 intimal hyperplasia was distinct and the endothe-
lium patchy. Furthermore, by extending the implantation
period to 6 months, we could demonstrate that diffuse
intimal hyperplasia – often regarded as a self-limiting
process25,26 – seems to continuously progress during the
first 6 months. Compared with 6-week and 12-week im-
plants,19 the thickness of the intimal hyperplasia tissue of
control grafts had increased 3.5- to 5.5-fold. When com-
paring the non mesh-supported control groups, the thick-
ness of neointimal tissue was identical in untreated grafts
and those that were spray-coated with a layer of fibrin glue.
External coating with hydrogels such as polyethylene glycol
or fibrin was previously suggested to suppress vein graft
degeneration.27 As much as fibrin glue-coating led to a
distinct fibrotic response in the adventitia and to a moder-
ately narrower lumen, the cross-sectional ratio only in-
creased to Qc  0.27, well below the assumed threshold
affecting intimal hyperplasia excluding a beneficial effect of
fibrin glue on its own and, thus, the possibility that it is the
fibrin glue used for the attachment of the mesh to the veins
Fig 7. Rare vein wall redundance in mesh-constricted graft: of all
the implants only one mesh-constricted vein graft showed signs of
longitudinal folding at 6 weeks. Interestingly, the media had
undergone the same changes as in areas where it rested directly on
the Nitinol mesh. While the compacted atrophied media lies
directly underneath the surface endothelium, the fold contains
only the loose adventitial tissue typically filling the space between
media and mesh. The empty voids which contained the Nitinol
struts are surrounded by fibrous issue (resin sections after de-
resining; Masson’s trichrome stain; original magnification 40).rather than the mesh itself that protects the vein grafts.However, while we were able to separate the overlapping
effects of mesh support and fibrin glue-spraying, the mid-
graft and anastomotic effect of mesh support were insepa-
rable as these meshes extended across the anastomoses.
Since subsequently developed meshes are knitted and do
not fray, follow-up experiments will allow the mesh support
to be limited to within the anastomotic suture line – a sine
qua non for emulating clinically used end-to-side anasto-
moses.
Apart from intimal hyperplasia, control veins showed a
significantly thickened wall of which the neointima only
comprised 42% and 26% in the untreated and the fibrin
glue-coated group, respectively. The lower proportion of
neointimal tissue within the wall of the fibrin glue-coated
group is explained by the thicker adventitia. Overall, the
histology of the graft wall after 6 months of implantation
entirely contradicted the often used term ‘arterialization of
vein grafts’.28,29 Apart from the accumulation of collagen
in the adventitia, the absolute mass of smooth muscle tissue
in the media had distinctly diminished confirming early
observations of the 1970s.30 While the thickness of the
media remained unchanged over the 6-month implantation
period, the proportion of smooth muscle cells vs collage-
nous connective tissue had significantly shifted from 64% to
36% in the untreated control group and from 52% to 34% in
the fibrin glue-coated control group.
The rationale behind constricting vein grafts with ex-
ternal meshes was twofold: (1) generally to suppress vein
graft pathology such as diffuse intimal hyperplasia and
endothelial detachment through a reduction in wall stress
and an increase in flow velocity and, thereby, shear forces;
and (2) to eliminate luminal irregularities and thus eddy
blood flow8 – a main trigger of focal intimal hyperplasia.13
We have previously shown in a similar senescent non-
human primate model that diameter constriction needs to
be seen against the size-mismatch between vein graft and
run-off artery.19 While a diameter constriction of 25% that
resulted in an increase in cross-sectional ratio from Qc 
0.22 to 0.45 led to a complete suppression of intimal
hyperplasia, a more extreme constriction by 50% (leading
to an increase of Qc to 1.2) was required to preserve
endothelial integrity.19 In contrast, identical Nitinol
meshes were incapable of the slightest mitigation of intimal
hyperplasia or endothelial detachment when size-matched
with the vein grafts.19 Given the fact that our observation
period was 6 months – far exceeding the regeneration time
of the endothelium,31,32 one can exclude the initial har-
vesting trauma as a reason for the endothelial loss seen in
the control groups. Thus, our observation indicates that
higher shear forces are required for preserving the endothe-
lium than for suppressing intimal hyperplasia.33 Since
threshold values of 5 dynes/cm2 were suggested for the
suppression of intimal hyperplasia, a value just reached by
the moderate 25% constriction in our previous experiments
– it appeared that threshold values for the preservation of
endothelium are closer to the 20 dynes/cm2 estimated for
the 50% constricted grafts.19 In our present experiments,
both mesh-constricted groups had exceeded this degree of
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intimal hyperplasia and preservation of endothelial integ-
rity. This coincides with previous observations where a
minimum shear stress of 7-14 dyn/cm2 was required for
p38 MAPK activation and endothelial alignment – a pro-
cess closely linked to the enhanced attachment of endothe-
lial cells.34 Furthermore, re-endothelialization after endo-
thelial loss proceeded much faster under high shear forces35
while disturbed flow with zones of low shear stress was
suggested to have the opposite effect.
Although our study does not allow the fine-titration of
a threshold value of cross-sectional ratio from which on-
wards intimal hyperplasia gets suppressed, our current find-
ings at least suggest ranges. While intimal hyperplasia was
completely unmitigated at a Qc of 0.27, mesh support
leading to a Qc of 0.88 was sufficient to prevent intimal
hyperplasia and retain full endothelial integrity. Thus, the
extreme constriction of vein grafts by pleated Nitinol
meshes leading to a 91% reduction in luminal area and a
cross-sectional ratio of Qc  3.1 had no further benefit on
diffuse intimal hyperplasia. In this context, it is important
to note that under experimental conditions the run-off
arteries are generally non-diseased. In a clinical set-up, the
effective ID of the mostly arteriosclerotically diseased run-
off vessels is often distinctly smaller, further exaggerating
the mismatch between vein graft and host artery. There-
fore, extreme constriction that shows no further advantage
under experimental conditions may still be beneficial under
clinical circumstances.
Given the fact that narrowing of a lumen is normally
associated with a pathologic process that threatens to lead
to vessel occlusion, mesh-constriction is certainly capable of
triggering uneasy associations in clinicians. Notwithstand-
ing these associations, the fact that external constriction
leads to the opposite, namely the complete suppression of
Table. Cross-sectional quotients (Qc) of grafts expressing
run-off artery. With a Qc of less than 0.2 in both control g
to be more than five times slower in the grafts than the art
groups could be expected to lead to 1.5 times and more th
the time of implantation. Over the initial 6 weeks, mesh di
almost size-matched luminal dimensions between mesh-su
refer to comparison with implant time point)
Treatment At implant
Controls 0.19  0.08
Controls 	 fibrin glue 0.17  0.10
Non-pleated meshes 1.47  0.43
Pleated meshes 3.09  0.80
NS, non-significant.pathological processes in the graft wall makes it inapt torefer to it as ‘luminal encroachment’.12 While the luminal
constriction, for instance, of coronary vein grafts to dimen-
sions corresponding with those of internal thoracic artery
grafts artificially ‘narrows’ the lumen, it leads to a mitiga-
tion of pathological degeneration and, thus, increases the
likelihood of long-term patency rather than diminishes it.
Although biomechanically confirmed,36 it is important to
emphasize that our observations were restricted to the use
of external Nitinol meshes where inflammatory and fibrotic
responses are minimal.19 The distinct adventitial fibrosis we
saw in the fibrin glue-sprayed group indicates that the
different results previously observed with non-degradable
and degradable synthetic meshes37 may well be material
related.
Exploring the possibility of extreme constriction in the
present study addressed two potential situations where such
measures may be required to optimize the benefit of mesh
support: one is the above-mentioned exaggeration of cali-
ber mismatch under clinical conditions due to narrowed
run-off vessels and the other is extreme caliber-fluctuation
within one and the same vein graft20 – a situation not
always avoidable when insufficient autologous graft mate-
rial is available. Caliber fluctuations lead to eddy blood flow
which in turn is known to trigger focal graft stenoses – the
main reason for the midterm failure of vein grafts.38 Al-
though a moderate constriction of 23% would be sufficient
for a majority of human saphenous vein grafts to elimi-
nate luminal irregularities,20 some veins would need to
be diameter-constricted by as much as 60% to achieve this.19
Apart from ‘encroaching’ the lumen,12 another intui-
tive concern of constriction is folding of the vein wall as a
consequence of excess circumference. In this regard, it was
interesting to see that a 50% diameter constriction leading
to a theoretical 52% redundancy of circumference of arte-
rially distended veins was largely accommodated without
atio of cross-sectional lumenal areas of grafts to their
s, mean flow velocities at implantation could be expected
onversely, the constrictions in the mesh supported
times faster flow velocities than in the run-off arteries at
ion led to an increase in inner diameter resulting in
ted grafts and run-off arteries (Statistical significances
Timepoint
42 days 180 days
— 0.20  0.04
NS
— 0.27  0.25
NS
0.82  0.31 0.91  0.13
NS P  .002
1.48  0.25 1.16  0.20






Qcfolding. While there were a few isolated areas of flat folds
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disappeared at 6 months. Since, except for intimal cush-
ions,20 the wall thickness and composition of baboon fem-
oral veins is comparable with that of human saphenous
veins,19 it is very likely that similar degrees of constriction
would not lead to obstructive tissue folds in clinical vein
grafts either. On the contrary, the complete absence of
folds in the pleated group in spite of identical circumferen-
tial dimensions suggests that ‘pre-folding’ may even act as a
means to absorb excess circumference. Human saphenous
veins may thus have an advantage over the baboon femoral
veins as they contain longitudinally ‘pre-folded’ intimal
cushions.20 Overall, however, it seems as if a contractile
conduit such as a vein is capable of accommodating signif-
icant caliber reduction without the formation of protruding
wall folds.
In summary, we could demonstrate in a senescent
non-human primate model that caliber adjustment of a vein
graft to its run-off artery through a constrictive external
mesh suppresses intimal hyperplasia and preserves endothe-
lial integrity over a prolonged period of time. By using
longitudinally pleated meshes made of the shape-memory
material Nitinol, even extreme constrictions to less than
10% of the original cross-sectional area could be achieved
without tissue folding or luminal encroachment.
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